Novan (NOVN) Posts Q3 Loss of $5.76/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Novan Reports Third Quarter 2016 Financial Results
November 14, 2016 9:29 AM ESTMORRISVILLE, N.C., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Novan, Inc. (the Company or Novan) (NASDAQ: NOVN) today announced the Companys financial results for the third quarter of 2016. Total operating expenses for the three months ended Sept. 30, 2016, were approximately $17.5 million, which includes research and development, or R&D, expenses totaling approximately $15.0 million and general and administrative, or G&A, expenses totaling approximately $2.5 million. Total operating expenses for the three months ended Sept. 30, 2015, were approximately $5.6 million, which included R&D expenses totaling approximately $3.2 million and G&A expenses totaling approximately $2.4 million. The year-over-year... More
Novartis partners with prominent US health advocacy organizations to launch first social networking platform for heart failure patients and their loved ones
November 10, 2016 8:00 AM ESTEAST HANOVER, N.J., Nov. 10, 2016 /PRNewswire/ --Â Novartis Pharmaceuticals Corporation announced today the launch of Together in HF (www.TogetherinHF.com) a social network for members of the heart failure (HF) community in partnership with national patient and professional organizations supporting heart health. Together in HF is the first social network for HF patients and caregivers to share their stories, and support and inspire each other. Â Members can access HF information and other resources from leading patient and caregiver advocacy groups as well as professional medical associations.... More



